# Effects of BufferGel and PRO 2000/5 Gel in Men

> **NCT00016536** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 24 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Naphthalene 2-sulfonate polymer
- **DRUG:** Carbopol polymer

## Key facts

- **NCT ID:** NCT00016536
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 1997-05
- **Target enrollment:** 24 (—)
- **Last updated:** 2021-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00016536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00016536, "Effects of BufferGel and PRO 2000/5 Gel in Men". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00016536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*